SAFE Act of 2025

H.R. 1661/S. 775 - Save America's Forgotten Equines Act H.R. 8870 - BUILD America 250 Act H.R. 3623 - Horse Transportation Safety Act

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

EATS Act/Food Security and Farm Protection Act, Class B Animal Dealers, Animal Welfare Act H.R. 1661/S. 775 - Save America's Forgotten Equines Act H.R. 1291 - HEARTS Act H.R. 6660 - Replace Animal Tests Act

Client expense: Not reported · Firm income: $7,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Prevention of cruelty to animals, including equines (Save America's Forgotten Equines Act HR1661/S775), dogs (Goldies Act, HR349); companion animals (PUPP Act, HR4921); animals in disasters (Better CARE for Animals Act, HR3112/S1538); pets in disasters (PETSAFE Act, HR7438); pets in public housing (Pets Belong With Families Act, HR8378/S4361); FY2027 Agriculture Appropriations; FY2027 Interior Appropriations; Farm Bill(HR7567); BUILD America 250 Act (HR8870).

Client expense: $403,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE

General issues and legislative activities impacting the horse racing industry and all equine matters, including care, health, and safety of the horse; Horseracing Integrity and Safety Act of 2020 (P.L.116-260), S.775/H.R.1661, SAFE Act of 2025, S.1770/H.R.3378, Racehorse Health and Safety Act of 2025, and H.R.4630, WAGER Act of 2025.

Client expense: Not reported · Firm income: $20,000

Government targets: Agriculture, Dept of (USDA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE

General issues and legislative activities impacting the horse racing industry and all equine matters, including care, health, and safety of the horse; Horseracing Integrity and Safety Act of 2020 (P.L.116-260), S.775/H.R.1661, SAFE Act of 2025, S.1770/H.R.3378, Racehorse Health and Safety Act of 2025, and H.R.4630, WAGER Act of 2025.

Client expense: Not reported · Firm income: $10,000

Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE

BLM & USFS grazing regulations BLM Land health standards/assessments Cooperative monitoring, including MOUs and subsequent joint protocols Agency resource monitoring and data collection tools Wildfire policy; U.S. Wildland Fire Service policy Endangered Species Act revisions/modernization Grizzly Bear delisting regulations Gray Wolf Delisting; Pet and Livestock Protection Act and regulatory Mexican Gray Wolf ESA policy; delisting efforts NEPA policy, guidance and regulations; permitting reform Depredation policies, standards, and guidelines at APHIS and USFWS NRCS programs available to natural resource management Wild Horse and Burro Act funding and implementation Parochial grazing/land use bills H.R.6300/S.2787, Grasslands Grazing Act H.R.9533, FEES Act H.R.7567 (and Senate companion) Farm Bill 2026; nat res provisions, fire, forestry H.R.1110, Grazing for Wildfire Risk Reduction H.R.281/S.316, Grizzly Bear State Management Act H.R.302, Water Rights Protection Act H.R.1301, death tax repeal H.R.1897, the ESA Amendments Act H.R.2238, Ranching Without Red Tape Act H.R.1661/S.775, Save America's Forgotten Equines Act S.140, the Wildfire Prevention Act S.211, the Resiliency for Ranching and Natural Resource Conservation Health Act S.1306/H.R.845, to delist the Gray wolf H.R.471, Fix Our Forests Act Implementation of livestock depredation provisions in the H.R.1, the One Big Beautiful Bill Act International Year of Rangelands and Pastoralists resolutions Rangeland conservation (post-fire remediation and funding, post-WHB rehab, invasive species mitigation)

Client expense: Not reported · Firm income: $10,000

Government targets: Agriculture, Dept of (USDA), Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE, U.S. Fish & Wildlife Service (USFWS), U.S. Forest Service

Fiscal Year 2027 Appropriations oHorse Protection Act enforcement oWild horses and burros oHorse slaughter defund oAnimal testing alternatives oAnimal Welfare Act enforcement oAnimal fighting and Preventing Animal Cruelty and Torture Act enforcement oPets Evacuation and Transportation Standards implementation oBig Cat Public Safety Act enforcement oProtecting Animals with Shelter (PAWS) grants oHumane Methods of Slaughter Act enforcement oVeterinary Medicine Loan Repayment Program and Veterinary Services Grant Program oSupport Endangered Species Act implementation; oppose removal of ESA regulations oMultinational Species Conservation Fund, USFWS International Affairs and USFWS Office of Law Enforcement oWildlife trafficking oBring Animals Relief and Kibble (BARK) Act oShark Fins Sale Elimination Act Enforcement oWildlife Crossings Pilot Program oJohn H. Prescott Marine Mammal Rescue Assistance grant program oReducing hardship for international transportation of domestic animals oOppose primate infrastructure oOppose Save Our Bacon Act, Food Security and Farm Protection Act, and related legislation oOppose Pet Food Uniform Regulatory Reform (PURR) Act oOppose trophy hunting Imports oOppose M-44s oBlock funding to issue USDA licenses to those who would travel elephants overnight Authorizing legislation oPuppy Protection Act (H.R.2253/S. 4437) oPrevent All Soring Tactics (PAST) Act (H.R. 1684) oSave Americas Forgotten Equines (SAFE) Act (H.R.1661/S.775) oBetter CARE for Animals Act (H.R. 3112/S. 1538) oBring Animals Relief and Kibble (BARK) Act (H.R.3732/ S. 1939) oPeople and Animals Well-being (PAW) Act (H.R.1842) oProviding for Unhoused People and Pets (PUPP) Act of 2025 (H.R.4921) oEjiao Act (H.R. 5544) oVeterinary Services to Improve Public Health in Rural Communities Act (S.4365) oSave Animals Through Operational Shelters (SATOS) Act (H.R. 6716) oCanyons Law (H.R. 4180/ S. 2179) oWildlife Road Crossings Program Reauthorization Act (H.R.6078) oOppose Food Security and Farm Protection (S. 1326) Act oOppose Pet and Livestock Protection Act (H.R. 845/ S.1306) oOppose Healthy Dog Importation Act (H.R. 3349/S. 1725) oOppose Grizzly Bear State Management Act (H.R. 281/S. 445) oOppose Protecting Access for Hunters and Anglers Act (H.R. 556/S. 537) oOppose ESA Amendments Act (H.R. 1897) oOppose Pet Food Uniform Regulatory Reform (PURR) Act (H.R. 597) oOppose Enhancing Safety for Animals Act of 2025 (H.R. 4255) oOppose Save Our Bacon Act (H.R. 4673) oOppose Pacific Northwest Gray Wolves Relief Act of 2025 (H.R. 5171) oOppose Protecting Local Zoos Act (H.R. 7159) oConcerns with S.J. Res 69/ H.J. Res. 111 Farm Bill (H.R. 7567/Senate discussion draft) oPuppy Protection Act (H.R.2253/S. 4437) oBetter CARE for Animals Act (H.R. 3112/S. 1538) oSave Americas Forgotten Equines (SAFE) Act (H.R.1661/S.775) oProtecting Animals with Shelter (PAWS) grant program reauthorization oSupport for provisions advance alternatives to animal testing oWildlife corridors/crossings oAnimal Welfare Act protections and oversight oAlternative protein research oOppose Food Security and Farm Protection Act (S. 1326), Save Our Bacon Act (H.R. 4673) and any related attack on state and local agriculture laws oOppose Healthy Dog Importation Act oOppose weakening of dog protections oOppose mink fur industry development and expansion oOppose removal of ESA protections oOppose M-44s NDAA (H.R. 8800/S. 4784) oBring Animals Relief and Kibble (BARK) Act (H.R.3732/ S. 1939) oOppose removal of ESA regulations oOppose waivers to permit live tissue trauma training BUILD America 250 Act (H.R. 8870) oReauthorization of the Wildlife Crossings Pilot Program oEnding transport of horses for slaughter Rulemaking and Federal Government Decisions and Policies oGrizzly Bears oHorse Protection Act enforcement oAnimal Welfare Act enforcement oNew Approach Methods to animal testing oWild Horses and Burros oWildlife trafficking oM-44s oBig Cats Public Safety Act oHunting/fishing regulations oShark fin sales elimination act and shark matters more generally oGod squad/Endangered Species Committee action oDepopulation oLine speeds for poultry and pork oListing pangolins and giraffes under the Endangered Species Act (and other foreign species) oEndangered Species Act Implementing Regulations oUSDA Animal Welfare Act regulations for dogs

Client expense: $280,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE

Save Americas Forgotten Equines Act HR 1661/S.775 and equine transportation issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Animal Welfare Enforcement Improvement Act -- To amend the Animal Welfare Act To increase protections for animals, and for other purposes. HR 4180 Canyon's Law -- To prohibit the use of M-44 devices, commonly known as "cyanide bombs", on public land, and for other purposes. HR 3199/S 1594 Captive Primate Safety Act -- To amend the Lacey Act Amendments of 1981 to prohibit certain activities involving prohibited primate species DAMS for Beavers Act -- To establish a grant program for projects that use nonlethal coexistence measures to reduce property damage caused by native beavers HR 5203 Ejiao Act of 2025 -- To prohibit the transportation, sale, and purchase of donkeys or donkey hides for the purpose of producing ejiao, to prohibit the transportation, sale, and purchase of products containing ejiao Endangered Species Act Ending Agricultural Trade Suppression Act (EATS Act) -- To prevent States and local jurisdictions from interfering with the production and distribution of agricultural products in interstate commerce HR 1897 ESA Amendments Act -- (oppose) To amend the Endangered Species Act of 1973 to optimize conservation. Farm Bill S 1326 Food Security and Farm Protection Act -- (oppose) To prevent States and local jurisdictions from interfering with the production and distribution of agricultural products in interstate commerce HR 556 Protecting Access for Hunter and Anglers Act -- (oppose) To prohibit prohibiting the use of lead ammunition or tackle on certain Federal land or water Horse slaughter HR 4776 SPEED Act -- (oppose) To amend and limit NEPA HR 7159 Protecting Local Zoos Act -- (oppose) To amend the Lacey Act Amendments of 1981 to adjust provisions relating to captive wildlife offenses. HR 5286 Humane Transport of Farmed Animals Act -- To develop an enforcement mechanism with respect to certain provisions relating to the transport of animals S 1529 Keep Finfish Free Act of 2025 -- To prohibit Federal agencies from authorizing or facilitating commercial finfish aquaculture operations in the Exclusive Economic Zone except in accordance with a Federal statute authorizing such action. Marine Mammal Protection Act S 1947 OCTOPUS Act -- To prohibit commercial octopus aquaculture operations in the United States HR 1684 PAST Act -- To expand horse soring regulations HR 1661/S 775 SAFE Act --. To amend the Agriculture Improvement Act of 2018 to prohibit the slaughter of equines for human consumption. *SWIMS Act -- To prohibit the taking, importation, exportation, and breeding of certain cetaceans for public display, and for other purposes.

Client expense: $40,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Justice, Dept of (DOJ), SENATE, U.S. Fish & Wildlife Service (USFWS)

Prevention of cruelty to animals, including equines (Save America's Forgotten Equines Act HR1661/S775), dogs (Goldies Act, HR349); companion animals (PUPP Act, HR4921); animals in disasters (Better CARE for Animals Act, HR3112/S1538); pets in disasters (PETSAFE Act, HR7438); pets in public housing (Pets Belong With Families Act, HR8378/S4361); FY2027 Agriculture Appropriations; FY2027 Interior Appropriations; FY2027 THUD Appropriations.

Client expense: $200,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE

Prevention of cruelty to animals, including equines (Save America's Forgotten Equines Act HR1661/S775), dogs (Goldies Act, HR349); companion animals (PUPP Act, HR4921); animals in disasters (Better CARE for Animals Act, HR3112/S1538); pets in disasters (PETSAFE Act, HR7438); pets in public housing (Pets Belong With Families Act, HR8378/S4361); FY2027 Agriculture Appropriations; FY2027 Interior Appropriations; FY2027 THUD Appropriations.

Client expense: $178,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE

General issues and legislative activities impacting the horse racing industry and all equine matters, including care, health, and safety of the horse; Horseracing Integrity and Safety Act of 2020 (P.L.116-260), S.775/H.R.1661, SAFE Act of 2025, S.1770/H.R.3378, Racehorse Health and Safety Act of 2025, and H.R.4630, WAGER Act of 2025.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General issues and legislative activities impacting the horse racing industry and all equine matters, including care, health, and safety of the horse; Horseracing Integrity and Safety Act of 2020 (P.L.116-260), S.775/H.R.1661, SAFE Act of 2025, S.1770/H.R.3378, Racehorse Health and Safety Act of 2025, and H.R.4630, WAGER Act of 2025.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

EATS Act/Food Security and Farm Protection Act, Class B Animal Dealers, Animal Welfare Act H.R. 1661/S. 775 - Save America's Forgotten Equines Act H.R. 1291 - HEARTS Act H.R. 6660 - Replace Animal Tests Act

Client expense: Not reported · Firm income: $7,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

BLM & USFS grazing regulations Cooperative monitoring Agency monitoring and reporting protocols Wildfire policy; U.S. Wildland Fire Service Sage Grouse ROD implementation Endangered Species Act revisions/modernization Grizzly Bear delisting regulations Gray Wolf Delisting; Pet and Livestock Protection Act and regulatory Mexican Gray Wolf ESA policy; delisting bill NEPA policy, guidance and regulations Depredation policies, standards, and guidelines at APHIS and USFWS NRCS programs available to natural resource management Wild Horse and Burro Act funding and implementation Parochial grazing/land use bills. H.R.1110, Grazing for Wildfire Risk Reduction H.R.281/S.316, Grizzly Bear State Management Act H.R.302, Water Rights Protection Act H.R.1301, death tax repeal H.R.1897, the ESA Amendments Act H.R.2238, Ranching Without Red Tape Act H.R.1661/S.775, Save America's Forgotten Equines Act S.140, the Wildfire Prevention Act S.211, the Resiliency for Ranching and Natural Resource Conservation Health Act S.1306/H.R.845, to delist the Gray wolf H.R.471, Fix Our Forests Act Implementation of livestock depredation provisions in the H.R.1, the One Big Beautiful Bill Act International Year of Rangelands and Pastoralists resolutions Rangeland conservation (post-fire remediation and funding, post-WHB rehab, invasive species mitigation)

Client expense: Not reported · Firm income: $5,000

Government targets: Agriculture, Dept of (USDA), Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE, U.S. Fish & Wildlife Service (USFWS), U.S. Forest Service

Authorizing legislation oPuppy Protection Act (H.R.2253) oPrevent All Soring Tactics (PAST) Act (H.R. 1684) oSave Americas Forgotten Equines (SAFE) Act (H.R.1661/S.775) oBetter CARE for Animals Act (H.R. 3112/S. 1538) oBring Animals Relief and Kibble (BARK) Act (H.R.3732/ S. 1939) oPeople and Animals Well-being (PAW) Act (H.R.1842) oProviding for Unhoused People and Pets (PUPP) Act of 2025 (H.R.4921) oEjiao Act (H.R. 5544) oVeterinary Services to Improve Public Health in Rural Communities Act (S.4365) oSave Animals Through Operational Shelters (SATOS) Act (H.R. 6716) oWildlife Road Crossings Program Reauthorization Act (H.R.6078) oOppose Food Security and Farm Protection (S. 1326) Act oOppose Pet and Livestock Protection Act (H.R. 845/ S.1306) oOppose Trust the Science Act (H.R. 130) oOppose Grizzly Bear State Management Act (H.R. 281/ S. 445) oOppose ESA Amendments Act (H.R. 1897) oOppose Pet Food Uniform Regulatory Reform (PURR) Act (H.R. 597) oOppose Enhancing Safety for Animals Act of 2025 (H.R. 4255) oOppose Save Our Bacon Act (H.R. 4673) oOppose Pacific Northwest Gray Wolves Relief Act of 2025 (H.R. 5171) oOppose Protecting Local Zoos Act (H.R. 7159) oConcerns with S.J. Res 69/ H.J. Res. 111 Farm Bill oPuppy Protection Act (H.R.) (H.R.2253) oBetter CARE for Animals Act (H.R. 3112/S. 1538) oOppose Food Security and Farm Protection Act (S. 1326), Save Our Bacon Act (H.R. 4673) and any related attack on state and local agriculture laws oOppose Section 12005 (Healthy Dog Importation Act, H.R. 3349) oOppose weakening of dog protections (Section 12604 (c) ) oOppose Mink Fur Industry Development/Expansion (Section 3201(d)) NDAA (H.R. 3838/S. 2296) o Bring Animals Relief and Kibble (BARK) Act (H.R.3732/ S. 1939) oOppose removal of ESA regulations Rulemaking and Federal Government Decisions and Policies oGray wolves oGrizzly Bears oHorse Protection Act enforcement oAnimal Welfare Act enforcement oNew Approach Methods to animal testing oWild Horses and Burros oWildlife trafficking oBig Cats Public Safety Act oTrophy hunting oShark fin sales elimination act and shark matters more generally oGod squad/Endangered Species Committee action oRetirement of animals used in research oListing pangolins and giraffes under the Endangered Species Act (and other foreign species) oFunding priorities for the FY27 Presidents Budget Request oEndangered Species Act Implementing Regulations oEvacuation of U.S. citizens pets from overseas in crises oUSDA Animal Welfare Act regulations for dogs oNIH DPCPSI Proposed Reorganization

Client expense: $220,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Land Management (BLM), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), White House Office

H.R. 1661 - Save America's Forgotten Equines Act S. 775 - Save America's Forgotten Equines Act Horse Slaughter Ban

Client expense: Not reported · Firm income: Not reported

H.R. 1661 - Save America's Forgotten Equines Act S. 775 - Save America's Forgotten Equines Act Horse Slaughter Ban

Client expense: Not reported · Firm income: Not reported

Prevention of cruelty to animals, including equines (Save America's Forgotten Equines Act HR1661/S775), dogs (Goldies Act, HR349;companion animals (PUPP Act, HR4921); animals in disasters (Better CARE for Animals Act, HR3112/S1538); pets in public housing (bill pending introduction); FY2026 Agriculture Appropriations; FY2026 Interior Appropriations; FY2026 THUD Appropriations.

Client expense: $162,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, SENATE

Prevention of cruelty to animals, including equines (Save America's Forgotten Equines Act HR1661/S775), dogs (Goldies Act, HR349;companion animals (PUPP Act, HR4921); animals in disasters (Better CARE for Animals Act, HR3112/S1538); pets in public housing (bill pending introduction); FY2026 Agriculture Appropriations; FY2026 Interior Appropriations; FY2026 THUD Appropriations.

Client expense: $162,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, SENATE

General issues and legislative activities impacting the horse racing industry and all equine matters, including care, health, and safety of the horse; Horseracing Integrity and Safety Act of 2020 (P.L.116-260), S.775/H.R.1661, SAFE Act of 2025, S.1770/H.R.3378, Racehorse Health and Safety Act of 2025, and H.R.4630, WAGER Act of 2025.

Client expense: Not reported · Firm income: $30,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

General issues and legislative activities impacting the horse racing industry and all equine matters, including care, health, and safety of the horse; Horseracing Integrity and Safety Act of 2020 (P.L.116-260), S.775/H.R.1661, SAFE Act of 2025, S.1770/H.R.3378, Racehorse Health and Safety Act of 2025, and H.R.4630, WAGER Act of 2025.

Client expense: Not reported · Firm income: $20,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Animal Welfare Enforcement Improvement Act -- To amend the Animal Welfare Act To increase protections for animals, and for other purposes. HR 4180 Canyon's Law -- To prohibit the use of M-44 devices, commonly known as "cyanide bombs", on public land, and for other purposes. HR 3199/S 1594 Captive Primate Safety Act -- To amend the Lacey Act Amendments of 1981 to prohibit certain activities involving prohibited primate species DAMS for Beavers Act -- To establish a grant program for projects that use nonlethal coexistence measures to reduce property damage caused by native beavers HR 5203 Ejiao Act of 2025 -- To prohibit the transportation, sale, and purchase of donkeys or donkey hides for the purpose of producing ejiao, to prohibit the transportation, sale, and purchase of products containing ejiao Endangered Species Act Ending Agricultural Trade Suppression Act (EATS Act) -- To prevent States and local jurisdictions from interfering with the production and distribution of agricultural products in interstate commerce HR 1897 ESA Amendments Act -- (oppose) To amend the Endangered Species Act of 1973 to optimize conservation. Farm Bill S 1326 Food Security and Farm Protection Act -- (oppose) To prevent States and local jurisdictions from interfering with the production and distribution of agricultural products in interstate commerce HR 556 Protecting Access for Hunter and Anglers Act -- (oppose) To prohibit prohibiting the use of lead ammunition or tackle on certain Federal land or water Horse slaughter HR 4776 SPEED Act -- (oppose) To amend and limit NEPA HR 7159 Protecting Local Zoos Act -- (oppose) To amend the Lacey Act Amendments of 1981 to adjust provisions relating to captive wildlife offenses. HR 5286 Humane Transport of Farmed Animals Act -- To develop an enforcement mechanism with respect to certain provisions relating to the transport of animals S 1529 Keep Finfish Free Act of 2025 -- To prohibit Federal agencies from authorizing or facilitating commercial finfish aquaculture operations in the Exclusive Economic Zone except in accordance with a Federal statute authorizing such action. Marine Mammal Protection Act S 1947 OCTOPUS Act -- To prohibit commercial octopus aquaculture operations in the United States HR 1684 PAST Act -- To expand horse soring regulations HR 1661/S 775 SAFE Act --. To amend the Agriculture Improvement Act of 2018 to prohibit the slaughter of equines for human consumption. HR 4673 Save Our Bacon Act -- (oppose) To ensure the free movement of livestock-derived products in interstate commerce. oSWIMS Act -- To prohibit the taking, importation, exportation, and breeding of certain cetaceans for public display, and for other purposes. HR 10292 Whale CHARTS Act -- To require the Secretary of Commerce to produce distribution maps for certain species of whales HR 4356 Wild Horse and Burro Protection Act of 2025 -- To prohibit certain uses of aircraft with respect to the management of wild free-roaming horses and burros

Client expense: $40,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Justice, Dept of (DOJ), SENATE, U.S. Fish & Wildlife Service (USFWS)

EATS Act/Food Security and Farm Protection Act, Class B Animal Dealers, Animal Welfare Act H.R. 1661/S. 775 - Save America's Forgotten Equines Act H.R. 1291 - HEARTS Act H.R. 6660 - Replace Animal Tests Act

Client expense: Not reported · Firm income: $7,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Save Americas Forgotten Equines Act HR 1661/S.775 and equine transportation issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

EATS Act/Food Security and Farm Protection Act, Class B Animal Dealers, Animal Welfare Act H.R. 1661/S. 775 - Save America's Forgotten Equines Act H.R. 1291 - HEARTS Act H.R. 6660 - Replace Animal Tests Act

Client expense: Not reported · Firm income: $7,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- BLM Grazing Regulations - USFS Grazing policies and regulations - Wildfire policies - Sage Grouse plan revisions (BLM) - Endangered Species Act revisions - Grizzly Bear Delisting - Gray Wolf Delisting - Mexican Gray Wolf ESA policy; delisting - NEPA policy, guidance and regulations - Wild Horse and Burro Act funding and implementation. H.R.1110, Grazing for Wildfire Risk Reduction H.R.281/S.316, Grizzly Bear State Management Act H.R.302, Water Rights Protection Act H.R.1301, death tax repeal H.R.1897, the ESA Amendments Act H.R.2238, Ranching Without Red Tape Act H.R.1661/S.775, Save America's Forgotten Equines Act S.140, the Wildfire Prevention Act S.211, the Resiliency for Ranching and Natural Resource Conservation Health Act S.1306, to delist the Gray wolf implementation of the H.R.1, the One Big Beautiful Bill Act

Client expense: Not reported · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE, U.S. Fish & Wildlife Service (USFWS), U.S. Forest Service

Authorizing legislation Puppy Protection Act (H.R.2253) Prevent All Soring Tactics (PAST) Act (H.R. 1684) Save Americas Forgotten Equines (SAFE) Act (H.R.1661/S.775) Better CARE for Animals Act (H.R. 3112/S. 1538) Bring Animals Relief and Kibble (BARK) Act (H.R.3732/ S. 1939) People and Animals Well-being (PAW) Act (H.R.1842) Providing for Unhoused People and Pets (PUPP) Act of 2025 (H.R.4921) Ejiao Act (H.R. 5544) Veterinary Services to Improve Public Health in Rural Communities Act (S.4365) Save Animals Through Operational Shelters (SATOS) Act (H.R. 6716) Wildlife Road Crossings Program Reauthorization Act (H.R.6078) Oppose Food Security and Farm Protection (S. 1326) Act Oppose Pet and Livestock Protection Act (H.R. 845/ S.1306) Oppose Trust the Science Act (H.R. 130) Oppose Grizzly Bear State Management Act (H.R. 281/ S. 445) Oppose ESA Amendments Act (H.R. 1897) Oppose Pet Food Uniform Regulatory Reform (PURR) Act (H.R. 597) Oppose Enhancing Safety for Animals Act of 2025 (H.R. 4255) Oppose Save Our Bacon Act (H.R. 4673) Oppose Pacific Northwest Gray Wolves Relief Act of 2025 (H.R. 5171) Concerns with S.J. Res 69/ H.J. Res. 111 Farm Bill Puppy Protection Act (H.R.) (H.R.2253) Better CARE for Animals Act (H.R. 3112/S. 1538) Oppose Food Security and Farm Protection Act (S. 1326), Save Our Bacon Act (H.R. 4673) and any related attack on state and local agriculture laws NDAA (H.R. 3838/S. 2296) Bring Animals Relief and Kibble (BARK) Act (H.R.3732/ S. 1939) Oppose removal of ESA regulations Rulemaking and Federal Government Decisions and Policies Gray wolves (listing and cancellation of the National Wolf Recovery Plan) Grizzly Bears Horse Protection Act enforcement Animal Welfare Act enforcement New Approach Methods to animal testing Animal Testing for UV Filters Wild Horses and Burros HISA Wildlife trafficking Big Cats Public Safety Act Importation permits for wildlife Trophy hunting CITES and CoP20 Proposal 4 related to giraffes NIH Chimpanzees Listing pangolins and giraffes under the Endangered Species Act (and other foreign species) Funding priorities for the FY27 Presidents Budget Request Endangered Species Act Implementing Regulations Twenty-Eight Hour Law regulations OSHA general duty clause - animal handling/performance Veterinary workforce shortages USDA permits to import dogs for adoption PACT Act Enforcement Desert tortoise/Florida panther protections under the ESA

Client expense: $180,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Labor, Dept of (DOL), SENATE, White House Office

Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R.1262 - Mikaela Naylon Give Kids a Chance Act To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Rep. McCaul, Michael T. [R-TX-10] S.932 - Give Kids a Chance Act of 2025 A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Sen. Mullin, Markwayne [R-OK]

Client expense: $265,983 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Save Americas Forgotten Equines Act HR 1661/S.775 and equine transportation issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R.1262 - Mikaela Naylon Give Kids a Chance Act To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Rep. McCaul, Michael T. [R-TX-10] S.932 - Give Kids a Chance Act of 2025 A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Sen. Mullin, Markwayne [R-OK] H.R.6609 - Pharmacists Fight Back in Medicare and Medicaid Act To amend titles XI, XVIII, and XIX of the Social Security Act to establish certain requirements under Medicare and Medicaid with respect to prescription drug benefits and pharmacy benefit managers. Sponsor: Rep. Auchincloss, Jake [D-MA-4] H.R.6610 - Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] To amend chapter 89 of title 5, United States Code, to limit the costs of pharmacy benefit managers with respect to Federal employee health benefit plans, and for other purposes. Sponsor: Rep. Auchincloss, Jake [D-MA-4]

Client expense: $90,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R.1262 - Mikaela Naylon Give Kids a Chance Act To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Rep. McCaul, Michael T. [R-TX-10] S.932 - Give Kids a Chance Act of 2025 A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Sen. Mullin, Markwayne [R-OK] H.R.6609 - Pharmacists Fight Back in Medicare and Medicaid Act To amend titles XI, XVIII, and XIX of the Social Security Act to establish certain requirements under Medicare and Medicaid with respect to prescription drug benefits and pharmacy benefit managers. Sponsor: Rep. Auchincloss, Jake [D-MA-4] H.R.6610 - Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] To amend chapter 89 of title 5, United States Code, to limit the costs of pharmacy benefit managers with respect to Federal employee health benefit plans, and for other purposes. Sponsor: Rep. Auchincloss, Jake [D-MA-4]

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

Issues related to animal welfare, including H.R. 3732 - BARK Act of 2025; H.R. 3112/S. 1538 - Better CARE for Animals Act of 2025; H.R. 2253 - Puppy Protection Act of 2025; H.R. 1661/S. 775 - Save America's Forgotten Equines (SAFE) Act; Issues related to Fiscal Year 2026 appropriations.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R.1262 - Mikaela Naylon Give Kids a Chance Act To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Rep. McCaul, Michael T. [R-TX-10] S.932 - Give Kids a Chance Act of 2025 A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Sen. Mullin, Markwayne [R-OK] H.R.6609 - Pharmacists Fight Back in Medicare and Medicaid Act To amend titles XI, XVIII, and XIX of the Social Security Act to establish certain requirements under Medicare and Medicaid with respect to prescription drug benefits and pharmacy benefit managers. Sponsor: Rep. Auchincloss, Jake [D-MA-4] H.R.6610 - Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] To amend chapter 89 of title 5, United States Code, to limit the costs of pharmacy benefit managers with respect to Federal employee health benefit plans, and for other purposes. Sponsor: Rep. Auchincloss, Jake [D-MA-4]

Client expense: $1,440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2]

Client expense: $28,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General issues and legislative activities impacting the horse racing industry and all equine matters, including care, health, and safety of the horse; Horseracing Integrity and Safety Act of 2020 (P.L.116-260), S.775/H.R.1661, SAFE Act of 2025, S.1770/H.R.3378, Racehorse Health and Safety Act of 2025, and H.R.4630, WAGER Act of 2025.

Client expense: Not reported · Firm income: $30,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

General issues and legislative activities impacting the horse racing industry and all equine matters, including care, health, and safety of the horse; Horseracing Integrity and Safety Act of 2020 (P.L.116-260), S.775/H.R.1661, SAFE Act of 2025, S.1770/H.R.3378, Racehorse Health and Safety Act of 2025, and H.R.4630, WAGER Act of 2025.

Client expense: Not reported · Firm income: $20,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Prevention of cruelty to animals, including equines (Save America's Forgotten Equines Act HR1661/S775), dogs (Goldies Act, HR349;companion animals (PUPP Act, HR4921); animals in disasters (Better CARE for Animals Act, HR3112/S1538); pets in public housing (bill pending introduction); FY2026 Agriculture Appropriations; FY2026 Interior Appropriations; FY2026 THUD Appropriations.

Client expense: $84,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

- BLM Grazing Regulations - USFS Grazing handbook and directives - Wildfire policy - Sage Grouse plan revisions (BLM) - Endangered Species Act revisions - Grizzly Bear Delisting - Gray Wolf Delisting - Mexican Gray Wolf ESA policy; delisting - NEPA policy, guidance and regulations - Wild Horse and Burro Act funding and implementation. H.R.1110, Grazing for Wildfire Risk Reduction H.R.281/S.316, Grizzly Bear State Management Act H.R.302, Water Rights Protection Act H.R.1301, death tax repeal H.R.1897, the ESA Amendments Act H.R.2238, Ranching Without Red Tape Act H.R.1661/S.775, Save America's Forgotten Equines Act S.140, the Wildfire Prevention Act S.211, the Resiliency for Ranching and Natural Resource Conservation Health Act S.1306, to delist the Gray wolf H.R.1, the One Big Beautiful Bill Act

Client expense: Not reported · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE, U.S. Fish & Wildlife Service (USFWS), U.S. Forest Service

Authorizing legislation Puppy Protection Act (H.R.2253) Prevent All Soring Tactics (PAST) Act (H.R. 1684) Save Americas Forgotten Equines (SAFE) Act (H.R.1661/S.775) Better CARE for Animals Act (H.R. 3112/S. 1538) Captive Primate Safety Act (H.R. 3199/S. 1594) Bring Animals Relief and Kibble (BARK) Act (H.R.3732/ S. 1939) Canyons Law (H.R. 4180/S. 2179) Humane Cosmetics Act (H.R. 1657) People and Animals Well-being (PAW) Act (H.R.1842) ProTECT Act (H.R. 1934) Opposing the Cultivation and Trade of Octopus Produced through Unethical Strategies (OCTOPUS) Act (S. 1947) Mink VIRUS Act (H.R. 2185) Cold-blooded Animal Research and Exhibition Act (H.R. 2976) Providing for Unhoused People and Pets (PUPP) Act of 2025 (H.R.4921) Humane Transport of Farmed Animals Act (H.R. 5286) Ejiao Act (H.R. 5544) National Animal Rescue Day Resolution (H.Res.781) Veterinary Services to Improve Public Health in Rural Communities Act (S.4365) Oppose Food Security and Farm Protection (S. 1326) Act Oppose Pet and Livestock Protection Act (H.R. 845/ S.1306) Oppose Trust the Science Act (H.R. 130) Oppose Grizzly Bear State Management Act (H.R. 281/ S. 445) Oppose ESA Amendments Act (H.R. 1897) Oppose Pet Food Uniform Regulatory Reform (PURR) Act (H.R. 597) Oppose Enhancing Safety for Animals Act of 2025 (H.R. 4255) Oppose Save Our Bacon Act (H.R. 4673) Oppose Pacific Northwest Gray Wolves Relief Act of 2025 (H.R. 5171) Farm Bill Puppy Protection Act (H.R.) (H.R.2253) Better CARE for Animals Act (H.R. 3112/S. 1538) Oppose Food Security and Farm Protection Act (S. 1326), Save Our Bacon Act (H.R. 4673) and any related attack on state and local agriculture laws NDAA (H.R. 3838/S. 2296) Inclusion of Bring Animals Relief and Kibble (BARK) Act (H.R.3732/ S. 1939) Oppose removal of ESA regulations Rulemaking and Federal Government Decisions and Policies Gray wolves Grizzly Bears Access to public lands/hunting of native carnivores on federal lands Horse Protection Act enforcement Animal Welfare Act enforcement New Approach Methods to animal testing Animal Testing for UV Filters Wild Horses and Burros HISA Wildlife trafficking Big Cats Public Safety Act Trophy hunting Wildlife corridors CITES and CoP20 Proposal 4 related to giraffes NIH Chimpanzees Listing pangolins under the Endangered Species Act (and other foreign species) Pork and poultry processing line speeds Funding priorities for the FY26 Presidents Budget Request Endangered Species Act Implementing Regulations Twenty-Eight Hour Law regulations OSHA general duty clause - animal handling/performance

Client expense: $250,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), White House Office

Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2]

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2]

Client expense: $1,150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2]

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

Prevention of cruelty to animals, including equines (Save America's Forgotten Equines Act HR1661/S775) and dogs (Goldies Act, HR 349); FY2026 Agriculture Appropriations; FY2026 Interior Appropriations.

Client expense: $57,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE